{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T16:42:32Z","timestamp":1786207352022,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1245\/s10434-026-19777-w","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T19:01:42Z","timestamp":1778266902000},"page":"8526-8533","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and Safety of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Recurrent Uterine Leiomyosarcoma: Results of a Phase 2 Study"],"prefix":"10.1245","volume":"33","author":[{"given":"Beatrice J.","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie Y.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marti","family":"Lohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Mokhtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Siy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Cunanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen N.","family":"Ganjoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1950-0262","authenticated-orcid":false,"given":"Byrne","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"issue":"1","key":"19777_CR1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ygyno.2017.02.019","volume":"145","author":"S Ricci","year":"2017","unstructured":"Ricci S, Stone RL, Fader AN. Uterine leiomyosarcoma: epidemiology, contemporary treatment strategies and the impact of uterine morcellation. Gynecol Oncol. 2017;145(1):208\u201316. https:\/\/doi.org\/10.1016\/j.ygyno.2017.02.019.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"19777_CR2","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/cncr.23245","volume":"112","author":"DS Kapp","year":"2008","unstructured":"Kapp DS, Shin JY, Chan JK. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas. Cancer. 2008;112(4):820\u201330. https:\/\/doi.org\/10.1002\/cncr.23245.","journal-title":"Cancer"},{"issue":"33","key":"19777_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021766","volume":"99","author":"L Wang","year":"2020","unstructured":"Wang L, Li S, Zhang Z, Jia J, Shan B. Prevalence and occult rates of uterine leiomyosarcoma. Medicine. 2020;99(33):e21766. https:\/\/doi.org\/10.1097\/MD.0000000000021766.","journal-title":"Medicine"},{"issue":"10","key":"19777_CR4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.diii.2019.07.007","volume":"100","author":"S Sun","year":"2019","unstructured":"Sun S, Bonaffini PA, Nougaret S, et al. How to differentiate uterine leiomyosarcoma from leiomyoma with imaging. Diagn Interv Imaging. 2019;100(10):619\u201334. https:\/\/doi.org\/10.1016\/j.diii.2019.07.007.","journal-title":"Diagn Interv Imaging"},{"issue":"8","key":"19777_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/cancers14081966","volume":"14","author":"K \u017bak","year":"2022","unstructured":"\u017bak K, Zaremba B, Rajtak A, Kotarski J, Amant F, Bobi\u0144ski M. Preoperative differentiation of uterine leiomyomas and leiomyosarcomas: current possibilities and future directions. Cancers. 2022;14(8):8. https:\/\/doi.org\/10.3390\/cancers14081966.","journal-title":"Cancers"},{"issue":"12","key":"19777_CR6","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1634\/theoncologist.2018-0095","volume":"23","author":"RC Arend","year":"2018","unstructured":"Arend RC, Toboni MD, Montgomery AM, et al. Systemic treatment of metastatic\/recurrent uterine leiomyosarcoma: a changing paradigm. Oncologist. 2018;23(12):1533\u201345. https:\/\/doi.org\/10.1634\/theoncologist.2018-0095.","journal-title":"Oncologist"},{"issue":"11","key":"19777_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050058","volume":"7","author":"MA Seidman","year":"2012","unstructured":"Seidman MA, Oduyebo T, Muto MG, Crum CP, Nucci MR, Quade BJ. Peritoneal dissemination complicating morcellation of uterine mesenchymal neoplasms. PLoS One. 2012;7(11):e50058. https:\/\/doi.org\/10.1371\/journal.pone.0050058.","journal-title":"PLoS One"},{"issue":"2","key":"19777_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ygyno.2011.04.021","volume":"122","author":"JY Park","year":"2011","unstructured":"Park JY, Park SK, Kim DY, et al. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma. Gynecol Oncol. 2011;122(2):255\u20139. https:\/\/doi.org\/10.1016\/j.ygyno.2011.04.021.","journal-title":"Gynecol Oncol"},{"issue":"20","key":"19777_CR9","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1002\/cncr.28844","volume":"120","author":"S George","year":"2014","unstructured":"George S, Barysauskas C, Serrano C, et al. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma. Cancer. 2014;120(20):3154\u20138. https:\/\/doi.org\/10.1002\/cncr.28844.","journal-title":"Cancer"},{"key":"19777_CR10","unstructured":"Abu-Rustum NR. NCCN clinical practice guidelines in oncology (NCCN Guidelines) Uterine Neoplasms. Version 3.2025. National Comprehensive Cancer Network. Published online March 2025. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/uterine.pdf"},{"issue":"3","key":"19777_CR11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3892\/mco.2018.1560","volume":"8","author":"K Nakamura","year":"2018","unstructured":"Nakamura K, Kajiyama H, Utsumi F, et al. Secondary cytoreductive surgery potentially improves the oncological outcomes of patients with recurrent uterine sarcomas. Mol Clin Oncol. 2018;8(3):499\u2013503. https:\/\/doi.org\/10.3892\/mco.2018.1560.","journal-title":"Mol Clin Oncol"},{"issue":"7","key":"19777_CR12","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1136\/ijgc-2019-000355","volume":"29","author":"N Bizzarri","year":"2019","unstructured":"Bizzarri N, Ghirardi V, Di Fiore GLM, et al. Secondary cytoreductive surgery in recurrent uterine leiomyosarcoma: a multi-institutional study. Int J Gynecol Cancer. 2019;29(7):1134\u201340. https:\/\/doi.org\/10.1136\/ijgc-2019-000355.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"19777_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ygyno.2012.02.014","volume":"125","author":"MM Leitao","year":"2012","unstructured":"Leitao MM, Zivanovic O, Chi DS, et al. Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis. Gynecol Oncol. 2012;125(2):409\u201313. https:\/\/doi.org\/10.1016\/j.ygyno.2012.02.014.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"19777_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ygyno.2007.02.031","volume":"106","author":"RL Giuntoli","year":"2007","unstructured":"Giuntoli RL, Garrett-Mayer E, Bristow RE, Gostout BS. Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma. Gynecol Oncol. 2007;106(1):82\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2007.02.031.","journal-title":"Gynecol Oncol"},{"issue":"8","key":"19777_CR15","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1001\/jamaoncol.2021.0580","volume":"7","author":"RM Van Stein","year":"2021","unstructured":"Van Stein RM, Aalbers AGJ, Sonke GS, Van Driel WJ. Hyperthermic intraperitoneal chemotherapy for ovarian and colorectal cancer: a review. JAMA Oncol. 2021;7(8):1231. https:\/\/doi.org\/10.1001\/jamaoncol.2021.0580.","journal-title":"JAMA Oncol"},{"issue":"3","key":"19777_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2020.6363","volume":"156","author":"S Kusamura","year":"2021","unstructured":"Kusamura S, Barretta F, Yonemura Y, et al. The role of hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei after cytoreductive surgery. JAMA Surgery. 2021;156(3):e206363. https:\/\/doi.org\/10.1001\/jamasurg.2020.6363.","journal-title":"JAMA Surgery"},{"issue":"23","key":"19777_CR17","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/JCO.18.01688","volume":"37","author":"PE Bonnot","year":"2019","unstructured":"Bonnot PE, Piessen G, Kepenekian V, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. JCO. 2019;37(23):2028\u201340. https:\/\/doi.org\/10.1200\/JCO.18.01688.","journal-title":"JCO"},{"issue":"15","key":"19777_CR18","doi-asserted-by":"publisher","first-page":"12353","DOI":"10.3390\/ijms241512353","volume":"24","author":"I Psilopatis","year":"2023","unstructured":"Psilopatis I, Damaskos C, Garmpis N, et al. The role of hyperthermic intraperitoneal chemotherapy in uterine cancer therapy. IJMS. 2023;24(15):12353. https:\/\/doi.org\/10.3390\/ijms241512353.","journal-title":"IJMS"},{"issue":"6","key":"19777_CR19","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/IGC.0000000000001289","volume":"28","author":"TP D\u00edaz-Montes","year":"2018","unstructured":"D\u00edaz-Montes TP, El-Sharkawy F, Lynam S, et al. Efficacy of hyperthermic intraperitoneal chemotherapy and cytoreductive surgery in the treatment of recurrent uterine sarcoma. Int J Gynecol Cancer. 2018;28(6):1130\u20137. https:\/\/doi.org\/10.1097\/IGC.0000000000001289.","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"19777_CR20","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1245\/s10434-015-4960-y","volume":"23","author":"P Sugarbaker","year":"2016","unstructured":"Sugarbaker P, Ihemelandu C, Bijelic L. Cytoreductive surgery and HIPEC as a treatment option for laparoscopic resection of uterine leiomyosarcoma with morcellation: early results. Ann Surg Oncol. 2016;23(5):1501\u20137. https:\/\/doi.org\/10.1245\/s10434-015-4960-y.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"19777_CR21","doi-asserted-by":"publisher","first-page":"259.e1","DOI":"10.1016\/j.ajog.2013.11.002","volume":"210","author":"WA Jimenez","year":"2014","unstructured":"Jimenez WA, Sardi A, Nieroda C, Gushchin V. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of recurrent high-grade uterine sarcoma with peritoneal dissemination. Am J Obstet Gynecol. 2014;210(3):259.e1-259.e8. https:\/\/doi.org\/10.1016\/j.ajog.2013.11.002.","journal-title":"Am J Obstet Gynecol"},{"key":"19777_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.critrevonc.2015.10.020","volume":"98","author":"A Ducoulombier","year":"2016","unstructured":"Ducoulombier A, Cousin S, Kotecki N, Penel N. Gemcitabine-based chemotherapy in sarcomas: a systematic review of published trials. Crit Rev Oncol\/Hematol. 2016;98:73\u201380. https:\/\/doi.org\/10.1016\/j.critrevonc.2015.10.020.","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"1","key":"19777_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/358341","volume":"2012","author":"AAK Tentes","year":"2012","unstructured":"Tentes AAK, Kakolyris S, Kyziridis D, Karamveri C. Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy in the treatment of advanced epithelial ovarian cancer. J Oncol. 2012;2012(1):358341. https:\/\/doi.org\/10.1155\/2012\/358341.","journal-title":"J Oncol"},{"key":"19777_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/506571","volume":"2012","author":"AAK Tentes","year":"2012","unstructured":"Tentes AAK, Kyziridis D, Kakolyris S, et al. Preliminary results of hyperthermic intraperitoneal intraoperative chemotherapy as an adjuvant in resectable pancreatic cancer. Gastroenterol Res Pract. 2012;2012:506571. https:\/\/doi.org\/10.1155\/2012\/506571.","journal-title":"Gastroenterol Res Pract"},{"issue":"2","key":"19777_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187\u201396. https:\/\/doi.org\/10.1097\/SLA.0b013e3181b13ca2.","journal-title":"Ann Surg"},{"issue":"15","key":"19777_CR26","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1158\/1078-0432.CCR-24-0590","volume":"30","author":"GJ Hanna","year":"2024","unstructured":"Hanna GJ, Dennis MJ, Scarfo N, et al. Personalized ctDNA for monitoring disease status in head and neck squamous cell carcinoma. Clin Cancer Res. 2024;30(15):3329\u201336. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-0590.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"19777_CR27","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ygyno.2017.06.018","volume":"146","author":"ML Hensley","year":"2017","unstructured":"Hensley ML, Patel SR, von Mehren M, et al. Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: subgroup analysis of a phase 3, randomized clinical trial. Gynecol Oncol. 2017;146(3):531\u20137. https:\/\/doi.org\/10.1016\/j.ygyno.2017.06.018.","journal-title":"Gynecol Oncol"},{"issue":"13","key":"19777_CR28","doi-asserted-by":"publisher","first-page":"8156","DOI":"10.1245\/s10434-023-14222-8","volume":"30","author":"BJ Sun","year":"2023","unstructured":"Sun BJ, Yue TM, Xu N, Fowler C, Lee B. Impact of successful implementation of an enhanced recovery after surgery protocol for patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2023;30(13):8156\u201365. https:\/\/doi.org\/10.1245\/s10434-023-14222-8.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"19777_CR29","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.1245\/s10434-024-15120-3","volume":"31","author":"TM Yue","year":"2024","unstructured":"Yue TM, Sun BJ, Xu N, Ohkuma R, Fowler C, Lee B. Improved Postoperative pain management outcomes after implementation of Enhanced Recovery After Surgery (ERAS) protocol for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). Ann Surg Oncol. 2024;31(6):3769\u201377. https:\/\/doi.org\/10.1245\/s10434-024-15120-3.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"19777_CR30","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/j.ejso.2017.08.011","volume":"43","author":"A Sardi","year":"2017","unstructured":"Sardi A, Sipok A, Baratti D, et al. Multi-institutional study of peritoneal sarcomatosis from uterine sarcoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol. 2017;43(11):2170\u20137. https:\/\/doi.org\/10.1016\/j.ejso.2017.08.011.","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"19777_CR31","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1245\/s10434-010-1178-x","volume":"17","author":"D Baratti","year":"2010","unstructured":"Baratti D, Pennacchioli E, Kusamura S, et al. Peritoneal sarcomatosis: is there a subset of patients who may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy? Ann Surg Oncol. 2010;17(12):3220\u20138. https:\/\/doi.org\/10.1245\/s10434-010-1178-x.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"19777_CR32","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ygyno.2020.12.032","volume":"161","author":"S Matsuzaki","year":"2021","unstructured":"Matsuzaki S, Matsuzaki S, Chang EJ, Yasukawa M, Roman LD, Matsuo K. Surgical and oncologic outcomes of hyperthermic intraperitoneal chemotherapy for uterine leiomyosarcoma: a systematic review of literature. Gynecol Oncol. 2021;161(1):70\u20137. https:\/\/doi.org\/10.1016\/j.ygyno.2020.12.032.","journal-title":"Gynecol Oncol"},{"key":"19777_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2025.114042","volume":"311","author":"MD Ray","year":"2025","unstructured":"Ray MD, Kapoor R, Bn N. Multimodal management of peritoneal sarcomatosis in uterine sarcoma: long term outcomes from a single institute in India. Eur J Obstet Gynecol Reprod Biol. 2025;311:114042. https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114042.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"19777_CR34","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ygyno.2018.09.010","volume":"151","author":"ME Roberts","year":"2018","unstructured":"Roberts ME, Aynardi JT, Chu CS. Uterine leiomyosarcoma: a review of the literature and update on management options. Gynecol Oncol. 2018;151(3):562\u201372. https:\/\/doi.org\/10.1016\/j.ygyno.2018.09.010.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"19777_CR35","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1111\/IGC.0b013e3181acae50","volume":"19","author":"A Mahdavi","year":"2009","unstructured":"Mahdavi A, Monk BJ, Ragazzo J, et al. Pelvic Radiation improves local control after hysterectomy for uterine leiomyosarcoma. Int J Gynecol Cancer. 2009;19(6):1080\u20134. https:\/\/doi.org\/10.1111\/IGC.0b013e3181acae50.","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"19777_CR36","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.canrad.2019.04.001","volume":"23","author":"A Cordoba","year":"2019","unstructured":"Cordoba A, Prades J, Basson L, et al. Adjuvant management of operated uterine sarcomas: a single institution experience. Cancer\/Radioth\u00e9rapie. 2019;23(5):401\u20137. https:\/\/doi.org\/10.1016\/j.canrad.2019.04.001.","journal-title":"Cancer\/Radioth\u00e9rapie"},{"issue":"1","key":"19777_CR37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1748-717X-8-128","volume":"8","author":"P Wong","year":"2013","unstructured":"Wong P, Han K, Sykes J, et al. Postoperative radiotherapy improves local control and survival in patients with uterine leiomyosarcoma. Radiat Oncol. 2013;8(1):128. https:\/\/doi.org\/10.1186\/1748-717X-8-128.","journal-title":"Radiat Oncol"},{"issue":"4","key":"19777_CR38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.currproblcancer.2019.06.001","volume":"43","author":"KN Ganjoo","year":"2019","unstructured":"Ganjoo KN. Uterine sarcomas. Curr Probl Cancer. 2019;43(4):283\u20138. https:\/\/doi.org\/10.1016\/j.currproblcancer.2019.06.001.","journal-title":"Curr Probl Cancer"},{"issue":"11","key":"19777_CR39","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1093\/annonc\/mdx484","volume":"28","author":"JY Blay","year":"2017","unstructured":"Blay JY, Soibinet P, Penel N, et al. Improved survival using specialized multidisciplinary board in sarcoma patients. Ann Oncol. 2017;28(11):2852\u20139. https:\/\/doi.org\/10.1093\/annonc\/mdx484.","journal-title":"Ann Oncol"},{"issue":"12","key":"19777_CR40","doi-asserted-by":"publisher","first-page":"7682","DOI":"10.1245\/s10434-024-15902-9","volume":"31","author":"BJ Sun","year":"2024","unstructured":"Sun BJ, Li AY, Hur DG, et al. Circulating tumor DNA in the monitoring of soft tissue sarcoma treatment and recurrence. Ann Surg Oncol. 2024;31(12):7682\u20134. https:\/\/doi.org\/10.1245\/s10434-024-15902-9.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"19777_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3390\/cancers15010157","volume":"15","author":"M Zhou","year":"2022","unstructured":"Zhou M, Bui N, Rathore R, et al. Feasibility of longitudinal ctDNA assessment in patients with uterine and extra-uterine leiomyosarcoma. Cancers. 2022;15(1):157. https:\/\/doi.org\/10.3390\/cancers15010157.","journal-title":"Cancers"},{"issue":"2","key":"19777_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.107319","volume":"50","author":"C Richaud","year":"2024","unstructured":"Richaud C, Jochum F, Journo G, et al. Impact of guideline adherence and expert center referral on the early management and outcomes of uterine sarcoma patients: a retrospective analysis from the French NETSARC network. Eur J Surg Oncol. 2024;50(2):107319. https:\/\/doi.org\/10.1016\/j.ejso.2023.107319.","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"19777_CR43","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/annonc\/mdz124","volume":"30","author":"JY Blay","year":"2019","unstructured":"Blay JY, Honor\u00e9 C, Stoeckle E, et al. Surgery in reference centers improves survival of sarcoma patients: a nationwide study. Ann Oncol. 2019;30(7):1143\u201353. https:\/\/doi.org\/10.1093\/annonc\/mdz124.","journal-title":"Ann Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19777-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19777-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19777-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:48:24Z","timestamp":1786204104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19777-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["19777"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19777-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}